Cannabis News Box

https://globenewswire.com/news-release/2018/06/25/1529165/0/en/GW-Pharmaceuticals-plc-and-its-U-S-Subsidiary-Greenwich-Biosciences-Announce-FDA-Approval-of-EPIDIOLEX-cannabidiol-oral-solution-the-First-Plant-derived-Cannabinoid-Prescription-Me.html

GW Pharmaceuticals turns over $108M in Q4 sales thanks to CBD-based medicine

Bethan Rose Jenkins, Cannabis News Writer/Editorial January 27, 2020

Following the EU approval of a cannabis-derived epilepsy treatment called Epidiolex, British drugs company GW Pharmaceuticals is experiencing a major surge in sales. Headquartered in London, GW Pharma...

Load More Stories

Comments (0)

All Cannabis News Box Picks Reader Picks Sort: Newest
Activate Search
Annual J.P. Morgan Healthcare Conference